These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells. Appaiahgari MB; Vrati S Vaccine; 2004 Sep; 22(27-28):3669-75. PubMed ID: 15315846 [TBL] [Abstract][Full Text] [Related]
4. Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines. Abe M; Shiosaki K; Hammar L; Sonoda K; Xing L; Kuzuhara S; Kino Y; Holland Cheng R Virus Res; 2006 Nov; 121(2):152-60. PubMed ID: 16815584 [TBL] [Abstract][Full Text] [Related]
5. Comparison of viral glycosylation using lectin blotting with Vero cell-derived and mouse brain-derived Japanese encephalitis vaccines. Toriniwa H; Komiya T Vaccine; 2011 Feb; 29(10):1859-62. PubMed ID: 21195800 [TBL] [Abstract][Full Text] [Related]
6. Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study. Schuller E; Jilma B; Voicu V; Golor G; Kollaritsch H; Kaltenböck A; Klade C; Tauber E Vaccine; 2008 Aug; 26(34):4382-6. PubMed ID: 18599165 [TBL] [Abstract][Full Text] [Related]
7. Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor. Toriniwa H; Komiya T Biologicals; 2007 Oct; 35(4):221-6. PubMed ID: 17400474 [TBL] [Abstract][Full Text] [Related]
8. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine. Lim CK; Takasaki T; Kotaki A; Kurane I Virology; 2008 Apr; 374(1):60-70. PubMed ID: 18221765 [TBL] [Abstract][Full Text] [Related]
9. [Study on a purified and inactivated Japanese encephalitis vaccine prepared on Vero cells using SA14-14-2 attenuated virus strain]. Yao Z; Dong G; Yu Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):191-3. PubMed ID: 12569794 [TBL] [Abstract][Full Text] [Related]
10. Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated). Kikukawa A; Gomi Y; Akechi M; Onishi T; Manabe S; Namazue J; Fuke I; Ishikawa T; Okuno Y; Ueda S Vaccine; 2012 Mar; 30(13):2329-35. PubMed ID: 22306856 [TBL] [Abstract][Full Text] [Related]
11. Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone. Mutoh E; Ishikawa T; Takamizawa A; Kurata T; Sata T; Kojima A Vaccine; 2004 Jun; 22(20):2599-608. PubMed ID: 15193385 [TBL] [Abstract][Full Text] [Related]
12. Study on persistent infection of Japanese encephalitis virus Beijing-1 strain in serum-free Sf9 cell cultures. Kim H; Lee SJ; Park JY; Park YW; Kim HS; Kang HY; Hur BK; Ryu YW; Han SI; Kim JS J Microbiol; 2004 Mar; 42(1):25-31. PubMed ID: 15357288 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine. Woolpert T; Staples JE; Faix DJ; Nett RJ; Kosoy OI; Biggerstaff BJ; Johnson BW; Sracic M; Fischer M Vaccine; 2012 Apr; 30(20):3090-6. PubMed ID: 22406277 [TBL] [Abstract][Full Text] [Related]
14. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies. Ferguson M; Johnes S; Li L; Heath A; Barrett A Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945 [TBL] [Abstract][Full Text] [Related]
15. Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus. Tiwari M; Parida M; Santhosh SR; Khan M; Dash PK; Rao PV Vaccine; 2009 Apr; 27(18):2513-22. PubMed ID: 19368794 [TBL] [Abstract][Full Text] [Related]
16. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Rourou S; van der Ark A; van der Velden T; Kallel H Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281 [TBL] [Abstract][Full Text] [Related]
17. Development of Vero cell-derived inactivated Japanese encephalitis vaccine. Sugawara K; Nishiyama K; Ishikawa Y; Abe M; Sonoda K; Komatsu K; Horikawa Y; Takeda K; Honda T; Kuzuhara S; Kino Y; Mizokami H; Mizuno K; Oka T; Honda K Biologicals; 2002 Dec; 30(4):303-14. PubMed ID: 12421588 [TBL] [Abstract][Full Text] [Related]
18. Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51. Schuller E; Klade CS; Heinz FX; Kollaritsch H; Rendi-Wagner P; Jilma B; Tauber E Vaccine; 2008 Nov; 26(48):6151-6. PubMed ID: 18804132 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta]. Bharati K; Rani R; Vrati S Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161 [TBL] [Abstract][Full Text] [Related]
20. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Liu CC; Lian WC; Butler M; Wu SC Vaccine; 2007 Jan; 25(1):19-24. PubMed ID: 16919374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]